А. В. Климов
Russian Cancer Research Center NN Blokhin · 35 works · 40 citations · h-index 4
Top works
- Surgical treatment of renal cell carcinoma with advanced tumor invasion of the inferior vena cava
- Resection of the inferior vena cava in patients with renal cell carcinoma with bulky tumor venous thrombosis
- Prognosis of patients operated on for renal cell carcinoma and tumor venous thrombosis: experience of the Urology Clinics, N.N. Blokhin National Medical Research Center of Oncology
- Predictors of the immediate results of thrombectomy in kidney cancer patients with venous tumor thrombosis
- Impact of surgical volume on functional results and cardiospecific survival rates in patients with clinically localized renal cancer
- Nephrectomy and thrombectomy in renal cell carcinoma patients with extensive tumor venous thrombosis: how to minimize surgical risks?
- Nephrectomy, inferior vena cava thrombectomy in renal cell carcinoma with tumor venous thrombosis and pulmonary metastases
- Safety of left renal vein ligation during circular resection of the inferior vena cava in right-side kidney carcinoma with tumor venous thrombosis
- Complications of partial nephrectomy in patients with tumors of solitary functioning kidney
- Tumor of the Renal Pelvis Accompanying Coral Nephrolithiasis
- Combination of lenvatinib and pembrolizumab in treatment of patients with metastatic renal cell carcinoma and factors of poor prognosis
- Безопасность и целесообразность использования трансперитонеального лапароскопического доступа для выполнения радикальной нефрэктомии при клинически локализованном раке почки
- ФУНКЦИОНАЛЬНЫЕ РЕЗУЛЬТАТЫ РАДИКАЛЬНОЙ НЕФРЭКТОМИИ ПРИ КЛИНИЧЕСКИ ЛОКАЛИЗОВАННОМ РАКЕ ПОЧКИ
- 954 The role of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma (mRCC) who are the candidates for targeted therapy
- Prognosis of patients with metastatic renal cell carcinoma following nephrectomy and metastasectomy
- Evolution of darolutamide evidence base: review of new data from international congresses and their role in personalization of systemic therapy selection
- P039 Pulmonary metastases (PM) of renal cell carcinoma (RCC): Results of surgical resection
- The combination of lenvatinib and pembrolizumab in the treatment of patients with metastatic kidney cancer and factors of poor prognosis: experience of clinics in Moscow: A prospective observational study
- Cytoreductive nephrectomy with tumour thrombectomy (CNT) in renal cell carcinoma (RCC) patients with pulmonary metastases
- Functional outcomes of repeat kidney resection in patients with cancer recurrence after nephron-sparing surgeries